111 related articles for article (PubMed ID: 33904678)
21. Imbalance of the two main circulating dendritic cell subsets in patients with myasthenia gravis.
Chen P; Li Y; Huang H; Li Y; Huang X; Chen Z; Liu X; Qiu L; Ou C; Huang Z; Lin Z; Ran H; Liu W
Clin Immunol; 2019 Aug; 205():130-137. PubMed ID: 30359772
[TBL] [Abstract][Full Text] [Related]
22. Maturation and cytokine production potential of dendritic cells isolated from rheumatoid arthritis patients peripheral blood and induced in vitro.
Sennikov SV; Falaleeva SA; Shkaruba NS; Chumasova OA; Obleukhova IA; Sizikov AE; Kurilin VV
Hum Immunol; 2016 Oct; 77(10):930-936. PubMed ID: 27421624
[TBL] [Abstract][Full Text] [Related]
23. Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus.
Robak E; Smolewski P; Wozniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2004; 15(3):222-30. PubMed ID: 15542447
[TBL] [Abstract][Full Text] [Related]
24. Catecholamines and pituitary function. VII: Effects of acute and chronic dopamine-receptor blockade on pituitary response to TRH-GNRH in normal women and in patients with hyperprolactinemic amenorrhea.
Giammartino C; Ambrosi F; Pelicci G; Pagliacci MC; Fedeli L; Nicoletti I
Horm Metab Res; 1988 Jan; 20(1):44-8. PubMed ID: 3131222
[TBL] [Abstract][Full Text] [Related]
25. Does elevated morning prolactin concentration in children always mean the diagnosis of hyperprolactinemia?
Stawerska R; Smyczyńska J; Hilczer M; Lewiński A
Exp Clin Endocrinol Diabetes; 2015 Jul; 123(7):405-10. PubMed ID: 26069077
[TBL] [Abstract][Full Text] [Related]
26. Alteration of balance between myeloid dendritic cells and plasmacytoid dendritic cells in peripheral blood of patients with asthma.
Matsuda H; Suda T; Hashizume H; Yokomura K; Asada K; Suzuki K; Chida K; Nakamura H
Am J Respir Crit Care Med; 2002 Oct; 166(8):1050-4. PubMed ID: 12379547
[TBL] [Abstract][Full Text] [Related]
27. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
Leaños-Miranda A; Chávez-Rueda KA; Blanco-Favela F
Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
[TBL] [Abstract][Full Text] [Related]
28. Anti-endothelial cell antibodies in the sera of hyperprolactinemic women.
Krause I; Blumenfeld Z; Malchinsky M; Cohen S; Blank M; Eldor A; Weksler B; Schweitzer K; Shoenfeld Y
Lupus; 1998; 7(6):377-82. PubMed ID: 9736319
[TBL] [Abstract][Full Text] [Related]
29. Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes.
De Schepper J; Schiettecatte J; Velkeniers B; Blumenfeld Z; Shteinberg M; Devroey P; Anckaert E; Smitz J; Verdood P; Hooghe R; Hooghe-Peters E
Eur J Endocrinol; 2003 Sep; 149(3):201-7. PubMed ID: 12943522
[TBL] [Abstract][Full Text] [Related]
30. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
[TBL] [Abstract][Full Text] [Related]
31. Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis.
Jongbloed SL; Lebre MC; Fraser AR; Gracie JA; Sturrock RD; Tak PP; McInnes IB
Arthritis Res Ther; 2006; 8(1):R15. PubMed ID: 16507115
[TBL] [Abstract][Full Text] [Related]
32. The effect of prolactin and bromocriptine on human peripheral immune status.
Kadioglu P; Açbay O; Demir G; Gazioglu N; Gundogdu S
J Endocrinol Invest; 2001 Mar; 24(3):147-51. PubMed ID: 11314742
[TBL] [Abstract][Full Text] [Related]
33. HYPERTHYROIDISM AND HYPERPROLACTINEMIA: IS THERE ANY ASSOCIATION?
Sanjari M; Safi Z; Tahroodi KM
Endocr Pract; 2016 Dec; 22(12):1377-1382. PubMed ID: 27540882
[TBL] [Abstract][Full Text] [Related]
34. Prolactin and thyroid-stimulating hormone responses to thyrotropin-releasing hormone in cases of hyperprolactinemia with normal and abnormal sella tomograms.
Badawy SZ; Moses A; Streeten D; Marshall L; Marlin D; Notman D
Int J Fertil; 1983; 28(4):213-8. PubMed ID: 6142012
[TBL] [Abstract][Full Text] [Related]
35. The influence of calcium infusion on serum prolactin in hyperprolactinemic women.
Yildiz L; Uyanik BS; Kuşkay S; Küçük M
J Basic Clin Physiol Pharmacol; 1995; 6(3-4):303-7. PubMed ID: 8852276
[TBL] [Abstract][Full Text] [Related]
36. [Anti-lung cancer effect of myeloid and plasmacytoid dendritic cell combined vaccines loaded with tumor cell lysates in vitro].
Tan JF; Zhong CH; Chen J; Guo QW; Kuang J; Zhang JH
Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):501-507. PubMed ID: 31357836
[No Abstract] [Full Text] [Related]
37. Blood myeloid dendritic cells from HIV-1-infected individuals display a proapoptotic profile characterized by decreased Bcl-2 levels and by caspase-3+ frequencies that are associated with levels of plasma viremia and T cell activation in an exploratory study.
Dillon SM; Friedlander LJ; Rogers LM; Meditz AL; Folkvord JM; Connick E; McCarter MD; Wilson CC
J Virol; 2011 Jan; 85(1):397-409. PubMed ID: 20962079
[TBL] [Abstract][Full Text] [Related]
38. Hyperprolactinemia and sexual function in men.
Buvat J; Lemaire A; Buvat-Herbaut M; Fourlinnie JC; Racadot A; Fossati P
Horm Res; 1985; 22(3):196-203. PubMed ID: 4054839
[TBL] [Abstract][Full Text] [Related]
39. Myeloid dendritic cells are decreased in peripheral blood of Alzheimer's disease patients in association with disease progression and severity of depressive symptoms.
Ciaramella A; Salani F; Bizzoni F; Orfei MD; Caltagirone C; Spalletta G; Bossù P
J Neuroinflammation; 2016 Jan; 13():18. PubMed ID: 26811068
[TBL] [Abstract][Full Text] [Related]
40. [Quantitive changes of circulating myeloid and plasmacytoid dendritic cell subsets in HBV infected patients during different periods of their infection].
Dong JL; Ma LN; Geng N
Zhonghua Gan Zang Bing Za Zhi; 2008 Dec; 16(12):893-6. PubMed ID: 19105931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
